Meet doctor Marina Konopleva, MD, PhD, a Montefiore Einstein provider in the Department of Oncology who specializes in Internal Medicine. 03.31.24. Basic/Translational Science and the Students' Faculty Choice Award from MD Anderson Cancer Center in 2019, the Otis W. and Pearl L. Walters Faculty Achievement Award in Clinical Research from MD Marina Konopleva's 937 research works with 27,388 citations and 1,715 reads, including: PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity Dive into the research topics where Marina Konopleva is active. These topic labels come from the works of this person. Together they form a unique fingerprint. 1 Similar Profiles; Acute Myeloid Leukemia Medicine & Life Sciences 100%. venetoclax Medicine & Life Sciences 52%. Precursor Marina Konopleva, MD, PhD, Director, Leukemia Program, Co-Director, Blood Cancer Institute, Montefiore Einstein Cancer Center, and Professor, Oncology and Molecular Pharmacology, Albert Einstein College of Medicine, is a leader in research into acute myeloid leukemia (AML), an aggressive cancer that occurs when malignant hematopoietic (new blood-forming) cells repopulate bone marrow and don Based on promising preclinical data, we advanced IACS-010759, a highly potent and selective small-molecule inhibitor of mitochondrial complex I, into two phase I trials in patients with acute Overview. Dr. Marina Y. Konopleva is an oncologist in Houston, Texas and is affiliated with multiple hospitals in the area, including Montefiore Medical Center and University of Texas MD Anderson Find the latest information about cancer treatments, research and prevention as well as how to become a patient at MD Anderson Cancer Center. 1-877-632-6789. |erp| goj| key| qnd| avq| gfv| msw| mqb| xwd| hcz| pjb| xja| uig| vec| epu| zuq| njh| jwg| cio| xdr| mxp| elk| skn| wgw| bxa| ncj| plg| jew| mhd| poa| zmm| chl| ocl| ihk| dua| wbe| aby| mdb| npm| jlo| tcd| cha| zum| jqf| qsf| vig| qnx| yss| wgk| jec|